There appears to be a low dose therapeutic window for alpha lipoic acid in both schizophrenia and ischemia reperfusion. Could disturbances in glutathione homeostasis, either through increased synthesis or reduced degradation be a factor? The half-life for both alpha lipoic acid and glutathione is very short.